Trial
NCT00376805
Allogeneic Natural Killer (NK) Cells in Patients With Advanced Metastatic Breast Cancer
Phase IITERMINATEDSAFETYConfidence: HIGH
Sponsor
Masonic Cancer Center, University of Minnesota
Collaborators
—
Condition
Breast Cancer
Intervention
Fludarabine
Why stopped
Withdrawn due to toxicity
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-12-28